Marker Therapeutics, Inc. (MRKR)
1.60
-0.01
(-0.62%)
USD |
NASDAQ |
Jan 30, 16:00
1.61
+0.01
(+0.62%)
After-Hours: 20:00
Marker Therapeutics Price : 1.60 for Jan. 30, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ADMA Biologics, Inc. | 17.30 |
| Viridian Therapeutics, Inc. | 33.00 |
| Kiniksa Pharmaceuticals International Plc | 43.92 |
| Neurocrine Biosciences, Inc. | 136.06 |
| AIM ImmunoTech, Inc. | 1.15 |
Price Related Metrics
| PS Ratio | 4.338 |
| PEG Ratio | -0.0953 |
| Price to Book Value | 1.451 |
| Earnings Yield | -76.81% |
| Market Cap | 26.68M |
| PEGY Ratio | -0.0953 |